Fuller & Thaler Asset Management, Inc. Bio Techne Corp Transaction History

Fuller & Thaler Asset Management, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2018 Nov 13, 2018	SELL	$147.44 - $204.11 $88,464 - $122,466	-600 Closed	0 $0
Q1 2018 May 14, 2018	BUY	$131.46 - $151.04 $78,876 - $90,624	600 New	600 $91,000
Q3 2017 Nov 08, 2017	SELL	$113.59 - $123.78 $34,077 - $37,134	-300 Closed	0 $0
Q2 2017 Aug 14, 2017	BUY	N/A	300	300 $35,000

601

151M

195K

53.2K

Ticker TECH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,222,600
Market Cap $2.7B
Description
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...

Get notified when there are updates to the investment portfolio of Fuller & Thaler Asset Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Fuller & Thaler Asset Management, Inc. with notifications on news.